WHWK
Whitehawk Therapeutics Inc
NASDAQ · USHealthcareBiotechnology
$3.79-2.57%
Price as of Jul 20, 2026
WHWK growth
Whitehawk Therapeutics Inc growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- -100.0%
- EBITDA
- —
- EBIT
- -94.3%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +26.8%
Three-year CAGR
- Revenue
- -22.3%
- EBITDA
- +68.3%
- EBIT
- -69.6%
- Net income
- +67.7%
- EPS
- +86.0%
- Free cash flow
- -60.1%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.